PATENT CLAIM ANALYSIS

Application Number: 16172312
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "314000"]

Abstract:
The present disclosure is concerned with oxadiazole and thiadiazole analogs that are capable of inhibiting TGF-β and methods of treating cancers such as, for example, multiple myeloma and a hematologic malignancy, and methods of treating fibrotic conditions using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claim (Index 17):
The method of  claim 14 , wherein the subject has been diagnosed with a need for treatment of the disorder prior to the administering step.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.41176
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15892302', '14913266', '14380659', '13974858', '15039763']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.827783722645051
- 35 USC 102 Novelty (BERT): 0.5906257538854202
- Combined Prediction Score: 0.8040679257690878
- Mean Citation Score: 518.051642
- Max Citation Score: 573.8161
- Similarity Product: 388.4062846291661

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test